Novartis ousts top Japanese execs amid fresh misconduct allegations

Save

Novartis has cracked down on its Japanese management. The Swiss drugmaker pushed out its top three executives Thursday, after a scathing report from a panel investigating misconduct in a leukemia drug trial.